Illness acceptance degree versus intensity of psychopathological symptoms in patients with psoriasis.

Authors:
Kostyła M; Tabała K; Kocur J.

Journal:
Postepy Dermatol Alergol

Publication Year: 2013

DOI:
10.5114/pdia.2013.35613

PMCID:
PMC3834715

PMID:
24278064

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Postepy Dermatol Alergol

Abbreviation: Postepy Dermatol Alergol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case of intractable pemphigoid gestationis that was prolonged after delivery and caused blisters …
Matsumoto T; Umemoto N; Sato H and 7 more (2023) - Transparency Score: 2/6
A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of pso…
Michalski P; Palazzo-Michalska V; Buda P and 4 more (2023) - Transparency Score: 2/6
Assessment of RANTES, MIP4A, MMP7, MMP9, MMP14, TIMP 1, TIMP 2 and TIMP 3 concentration in the foll…
Adamczak R; Ukleja-Sokołowska N; Lis K and 2 more (2023) - Transparency Score: 2/6
Autologous serum therapy reduces the symptoms and antihistamine burden in patients with chronic urt…
Mohammed JQ. (2023) - Transparency Score: 2/6
Behcet's disease in a patient with primary sclerosing cholangitis: a case report and literature rev…
Bielecka-Kowalska NP; Lewkowicz N. (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Research financed by the Medical University of Lodz from the funds: 502-03/7-128-03/502-54-093."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025